{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:37:31Z","timestamp":1792787851723,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Tianjin Health Research Project","award":["Nos. TJSJMYXYC-D2-027"],"award-info":[{"award-number":["Nos. TJSJMYXYC-D2-027"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Extraintestinal manifestations (EIMs) significantly affect the life quality of people with inflammatory bowel disease (IBD) and are crucial factors impacting occurrence rates and mortality among IBD patients. This study performed a Mendelian randomization (MR) analysis to investigate the causal relationships between genetically predicted IBD and the development of EIMs, including erythema nodosum (EN), episcleritis, scleritis, uveitis, primary sclerosing cholangitis (PSC), and spondyloarthritis. To further investigate differences between subtypes, separate analyses were conducted for ulcerative colitis (UC) and Crohn\u2019s disease (CD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study was conducted based on genome-wide association studies (GWAS) data. We carefully selected SNPs associated with both exposure and outcome by comparing and integrating data from GWAS and relevant literature, and prioritizing studies with large sample sizes, high quality, and as much population homogeneity as possible. The SNPs associated with IBD, UC and CD were extracted from the International Inflammatory Bowel Disease Genetics Consortium. And the SNPs associated with EIMs were extracted from the UK Biobank, the International PSC Study Group and the FinnGen study. A series of quality control steps were taken in our analysis to select eligible instrumental SNPs which were strongly associated with exposure. The causal effects were estimated using a primary analysis that employed inverse-variance weighting (IVW) and complementary analysis that utilized MR-Egger weighted by the median. A sensitivity analysis was conducted using the Cochran Q statistic, a funnel plot, the MR-Egger intercept, and a leave-one-out approach. Reverse causality analysis was also performed to ensure the robustness of the findings. Furthermore, a fixed-effects meta-analysis was employed to combine MR outcomes from various data origins, bolstering the strength and dependability of our findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Our findings indicated that genetically predicted IBD had a robust causal relationship with an increased risk of specific conditions, including EN (OR, 1.20; 95% CI, 1.09\u20131.32;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01), uveitis (OR, 1.15; 95% CI, 1.11\u20131.20;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01), PSC (OR, 1.21; 95% CI, 1.13\u20131.28;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01), and spondyloarthritis (OR, 1.19; 95% CI, 1.14\u20131.23;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01). In subgroup analyses, the causal effects of both UC and CD on EN, uveitis, PSC, and spondyloarthritis were also significant and robust. Additionally, no significant evidence of causality was observed between genetically predicted IBD, UC, and CD, and the occurrence of both episcleritis and scleritis. The results of reverse causality analysis indicated a robust causal association between genetically predicted PSC and the elevated risk of IBD (OR, 1.21; 95% CI, 1.15\u20131.29;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01), UC (OR, 1.27; 95% CI, 1.17\u20131.37;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01), and CD (OR, 1.10; 95% CI, 1.02\u20131.20;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01). Additionally, spondyloarthritis had a causal relationship with an increased risk of both IBD (OR, 1.03; 95% CI, 1.01\u20131.06;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01) and UC (OR, 1.05; 95% CI, 1.02\u20131.08;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s12876-024-03566-4","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T13:19:55Z","timestamp":1741094395000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The causal impact of genetically predicted inflammatory bowel disease on extraintestinal manifestations: a mendelian randomization study"],"prefix":"10.1186","volume":"25","author":[{"given":"Xingcan","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maorun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"key":"3566_CR1","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1053\/j.gastro.2021.07.042","volume":"16","author":"G Rogler","year":"2021","unstructured":"Rogler G, Singh A, Kavanaugh A, et al. Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management. Gastroenterology. 2021;16:1118\u201332.","journal-title":"Gastroenterology"},{"key":"3566_CR2","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s11894-003-0042-6","volume":"5","author":"T Orchard","year":"2003","unstructured":"Orchard T. Extraintestinal complications of inflammatory bowel disease. Curr Gastroenterol Rep. 2003;5:512\u20137.","journal-title":"Curr Gastroenterol Rep"},{"key":"3566_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/ecco-jcc\/jjv213","volume":"10","author":"M Harbord","year":"2016","unstructured":"Harbord M, Annese V, Vavricka SR, et al. The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease. J Crohns Colitis. 2016;10:239\u201354.","journal-title":"J Crohns Colitis"},{"key":"3566_CR4","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1093\/ibd\/izy318","volume":"25","author":"DA Mu\u00f1iz Pedrogo","year":"2019","unstructured":"Mu\u00f1iz Pedrogo DA, Chen J, Hillmann B, et al. An Increased Abundance of Clostridiaceae Characterizes Arthritis in Inflammatory Bowel Disease and Rheumatoid Arthritis: A Cross-sectional Study. Inflamm Bowel Dis. 2019;25:902\u201313.","journal-title":"Inflamm Bowel Dis"},{"key":"3566_CR5","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/ecco-jcc\/jjv238","volume":"10","author":"M Severs","year":"2016","unstructured":"Severs M, van Erp SJH, van der Valk ME, et al. Smoking is Associated With Extra-intestinal Manifestations in Inflammatory Bowel Disease. J Crohns Colitis. 2016;10:455\u201361.","journal-title":"J Crohns Colitis"},{"key":"3566_CR6","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1097\/MIB.0000000000000429","volume":"21","author":"SR Vavricka","year":"2015","unstructured":"Vavricka SR, Rogler G, Gantenbein C, et al. Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort. Inflamm Bowel Dis. 2015;21:1794\u2013800.","journal-title":"Inflamm Bowel Dis"},{"key":"3566_CR7","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/ecco-jcc\/jjy191","volume":"13","author":"CRH Hedin","year":"2019","unstructured":"Hedin CRH, Vavricka SR, Stagg AJ, et al. The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and Therapy. J Crohns Colitis. 2019;13:541\u201354.","journal-title":"J Crohns Colitis"},{"key":"3566_CR8","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.2165\/11638120-000000000-00000","volume":"72","author":"G Trikudanathan","year":"2012","unstructured":"Trikudanathan G, Venkatesh PGK, Navaneethan U. Diagnosis and therapeutic management of extra-intestinal manifestations of inflammatory bowel disease. Drugs. 2012;72:2333\u201349.","journal-title":"Drugs"},{"key":"3566_CR9","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1136\/gut.2009.199679","volume":"60","author":"CW Lees","year":"2011","unstructured":"Lees CW, Barrett JC, Parkes M, et al. New IBD genetics: common pathways with other diseases. Gut. 2011;60:1739\u201353.","journal-title":"Gut"},{"key":"3566_CR10","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/01.MIB.0000442011.60285.68","volume":"20","author":"A Weizman","year":"2014","unstructured":"Weizman A, Huang B, Berel D, et al. Clinical, serologic, and genetic factors associated with pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease patients. Inflamm Bowel Dis. 2014;20:525\u201333.","journal-title":"Inflamm Bowel Dis"},{"key":"3566_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.5217\/ir.2019.00128","volume":"18","author":"JM Kim","year":"2020","unstructured":"Kim JM, Cheon JH. Pathogenesis and clinical perspectives of extraintestinal manifestations in inflammatory bowel diseases. Intest Res. 2020;18:249\u201364.","journal-title":"Intest Res"},{"key":"3566_CR12","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1681\/ASN.2016010098","volume":"27","author":"P Sekula","year":"2016","unstructured":"Sekula P, Del Greco MF, Pattaro C, et al. Mendelian Randomization as an Approach to Assess Causality Using Observational Data. J Am Soc Nephrol. 2016;27:3253\u201365.","journal-title":"J Am Soc Nephrol"},{"key":"3566_CR13","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1001\/jama.2017.17219","volume":"318","author":"CA Emdin","year":"2017","unstructured":"Emdin CA, Khera AV, Kathiresan S, Mendelian Randomization. JAMA. 2017;318:1925\u20136.","journal-title":"JAMA"},{"key":"3566_CR14","unstructured":"Malik TF, Aurelio DM. Extraintestinal Manifestations of Inflammatory Bowel Disease. In: StatPearls. StatPearls Publishing; 2023. Accessed August 8, 2023. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK568797\/"},{"key":"3566_CR15","doi-asserted-by":"publisher","first-page":"1078963","DOI":"10.3389\/fnut.2023.1078963","volume":"10","author":"Z Yun","year":"2023","unstructured":"Yun Z, Nan M, Li X, et al. Processed meat, red meat, white meat, and digestive tract cancers: A two-sample Mendelian randomization study. Front Nutr. 2023;10:1078963.","journal-title":"Front Nutr"},{"key":"3566_CR16","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/ng.3359","volume":"4","author":"JZ Liu","year":"2015","unstructured":"Liu JZ, van Sommeren S, Huang H, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet. 2015;4:979\u201386.","journal-title":"Nat Genet"},{"key":"3566_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nature11582","volume":"491","author":"L Jostins","year":"2012","unstructured":"Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119\u201324.","journal-title":"Nature"},{"key":"3566_CR18","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","volume":"53","author":"S Sakaue","year":"2021","unstructured":"Sakaue S, Kanai M, Tanigawa Y, et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nat Genet. 2021;53:1415\u201324.","journal-title":"Nat Genet"},{"key":"3566_CR19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/ng.3745","volume":"49","author":"SG Ji","year":"2017","unstructured":"Ji SG, Juran BD, Mucha S, et al. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease. Nat Genet. 2017;49:269\u201373.","journal-title":"Nat Genet"},{"key":"3566_CR20","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1093\/ije\/dyv071","volume":"44","author":"AGC Boef","year":"2015","unstructured":"Boef AGC, Dekkers OM, le Cessie S. Mendelian randomization studies: a review of the approaches used and the quality of reporting. Int J Epidemiol. 2015;44:496\u2013511.","journal-title":"Int J Epidemiol"},{"key":"3566_CR21","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess S, Thompson SG, CRP CHD Genetics Collaboration. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40:755\u201364.","journal-title":"Int J Epidemiol"},{"key":"3566_CR22","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/brain\/awz413","volume":"143","author":"MK Georgakis","year":"2020","unstructured":"Georgakis MK, Malik R, Anderson CD, Hopewell JC, Dichgans M, et al. Genetic determinants of blood lipids and cerebral small vessel disease: role of high-density lipoprotein cholesterol. Brain. 2020;143:597\u2013610.","journal-title":"Brain"},{"key":"3566_CR23","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B, et al. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50:693\u20138.","journal-title":"Nat Genet"},{"key":"3566_CR24","unstructured":"Genetic and epigenetic fine mapping of causal autoimmune disease variants - PubMed. Accessed November 7. 2023. https:\/\/pubmed.ncbi.nlm.nih.gov\/25363779\/"},{"key":"3566_CR25","unstructured":"Histocompatibility antigens in inflammatory bowel disease. Their clinical significance and their association with arthropathy with special reference to HLA-B27 (W27) - PubMed. Accessed November 7. 2023. https:\/\/pubmed.ncbi.nlm.nih.gov\/1001980\/"},{"key":"3566_CR26","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/ng.2616","volume":"45","author":"JZ Liu","year":"2013","unstructured":"Liu JZ, Hov JR, Folseraas T, et al. Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat Genet. 2013;45:670\u20135.","journal-title":"Nat Genet"},{"key":"3566_CR27","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1093\/rheumatology\/keh589","volume":"44","author":"A Myers","year":"2005","unstructured":"Myers A, Kay LJ, Lynch SA, et al. Recurrence risk for psoriasis and psoriatic arthritis within sibships. Rheumatology (Oxford). 2005;44:773\u20136.","journal-title":"Rheumatology (Oxford)"},{"key":"3566_CR28","doi-asserted-by":"publisher","first-page":"104892","DOI":"10.1016\/j.phrs.2020.104892","volume":"159","author":"V Annese","year":"2020","unstructured":"Annese V. Genetics and epigenetics of IBD. Pharmacol Res. 2020;159:104892.","journal-title":"Pharmacol Res"},{"key":"3566_CR29","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1097\/MCG.0000000000000067","volume":"48","author":"T Sheth","year":"2014","unstructured":"Sheth T, Pitchumoni CS, Das KM. Musculoskeletal manifestations in inflammatory bowel disease: a revisit in search of immunopathophysiological mechanisms. J Clin Gastroenterol. 2014;48:308\u201317.","journal-title":"J Clin Gastroenterol"},{"key":"3566_CR30","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.3390\/biom10101461","volume":"10","author":"A Sharip","year":"2020","unstructured":"Sharip A, Kunz J. Understanding the Pathogenesis of Spondyloarthritis. Biomolecules. 2020;10:1461.","journal-title":"Biomolecules"},{"key":"3566_CR31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/jpm10040151","volume":"10","author":"R D\u00edaz-Pe\u00f1a","year":"2020","unstructured":"D\u00edaz-Pe\u00f1a R, Castro-Santos P, Dur\u00e1n J, Santiago C, et al. The Genetics of Spondyloarthritis. J Pers Med. 2020;10:151.","journal-title":"J Pers Med"},{"key":"3566_CR32","unstructured":"Primary sclerosing cholangitis associated with inflammatory bowel disease: an update - PubMed. Accessed November 7. 2023. https:\/\/pubmed.ncbi.nlm.nih.gov\/26636407\/"},{"key":"3566_CR33","unstructured":"The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis - PubMed. Accessed November 7. 2023. https:\/\/pubmed.ncbi.nlm.nih.gov\/17313496\/"},{"key":"3566_CR34","doi-asserted-by":"publisher","first-page":"649376","DOI":"10.3389\/fgene.2021.649376","volume":"12","author":"Y Xie","year":"2021","unstructured":"Xie Y, Chen X, Deng M, et al. Causal Linkage Between Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Two-Sample Mendelian Randomization Analysis. Front Genet. 2021;12:649376.","journal-title":"Front Genet"},{"key":"3566_CR35","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1136\/gut.27.1.86","volume":"2","author":"RW Chapman","year":"1986","unstructured":"Chapman RW, Cottone M, Selby WS, Sherlock S, Jewell DP, et al. Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis. Gut. 1986;2:86\u201391.","journal-title":"Gut"},{"key":"3566_CR36","doi-asserted-by":"publisher","first-page":"531","DOI":"10.14218\/JCTH.2021.00344","volume":"10","author":"T Da Cunha","year":"2022","unstructured":"Da Cunha T, Vaziri H, Wu GY. Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Review. J Clin Transl Hepatol. 2022;10:531\u201342.","journal-title":"J Clin Transl Hepatol"},{"key":"3566_CR37","doi-asserted-by":"publisher","first-page":"6213","DOI":"10.3748\/wjg.v28.i44.6213","volume":"2","author":"ZJ Li","year":"2022","unstructured":"Li ZJ, Gou HZ, Zhang YL, et al. Role of intestinal flora in primary sclerosing cholangitis and its potential therapeutic value. World J Gastroenterol. 2022;2:6213\u201329.","journal-title":"World J Gastroenterol"},{"key":"3566_CR38","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/hep.1840130425","volume":"13","author":"SN Lichtman","year":"1991","unstructured":"Lichtman SN, Keku J, Clark RL, et al. Biliary tract disease in rats with experimental small bowel bacterial overgrowth. Hepatology. 1991;13:766\u201372.","journal-title":"Hepatology"},{"key":"3566_CR39","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1136\/gut.2008.157818","volume":"59","author":"B Terjung","year":"2010","unstructured":"Terjung B, S\u00f6hne J, Lechtenberg B, et al. p-ANCAs in autoimmune liver disorders recognise human beta-tubulin isotype 5 and cross-react with microbial protein FtsZ. Gut. 2010;59:808\u201316.","journal-title":"Gut"},{"key":"3566_CR40","unstructured":"TGR5 sequence variation in primary sclerosing cholangitis - PubMed. Accessed November 7. 2023. https:\/\/pubmed.ncbi.nlm.nih.gov\/21691110\/"},{"key":"3566_CR41","doi-asserted-by":"publisher","first-page":"e289","DOI":"10.1111\/ijd.13212","volume":"55","author":"C De Simone","year":"2016","unstructured":"De Simone C, Caldarola G, Scaldaferri F, et al. Clinical, histopathological, and immunological evaluation of a series of patients with erythema nodosum. Int J Dermatol. 2016;55:e289\u2013294.","journal-title":"Int J Dermatol"},{"key":"3566_CR42","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1309\/3YJG2AWU06H0NX8G","volume":"130","author":"C Demirkesen","year":"2008","unstructured":"Demirkesen C, T\u00fcz\u00fcner N, Senocak M, et al. Comparative study of adhesion molecule expression in nodular lesions of Beh\u00e7et syndrome and other forms of panniculitis. Am J Clin Pathol. 2008;130:28\u201333.","journal-title":"Am J Clin Pathol"},{"key":"3566_CR43","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s12519-018-0191-1","volume":"14","author":"AKC Leung","year":"2018","unstructured":"Leung AKC, Leong KF, Lam JM. Erythema nodosum. World J Pediatr. 2018;14:548\u201354.","journal-title":"World J Pediatr"},{"key":"3566_CR44","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/ecco-jcc\/jjx158","volume":"12","author":"SR Vavricka","year":"2018","unstructured":"Vavricka SR, Galv\u00e1n JA, Dawson H, et al. Expression Patterns of TNF\u03b1, MAdCAM1, and STAT3 in Intestinal and Skin Manifestations of Inflammatory Bowel Disease. J Crohns Colitis. 2018;12:347\u201354.","journal-title":"J Crohns Colitis"},{"key":"3566_CR45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3109\/07853890903559724","volume":"42","author":"S Larsen","year":"2010","unstructured":"Larsen S, Bendtzen K, Nielsen OH. Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management. Ann Med. 2010;42:97\u2013114.","journal-title":"Ann Med"},{"key":"3566_CR46","doi-asserted-by":"publisher","first-page":"438402","DOI":"10.1155\/2015\/438402","volume":"2015","author":"R Mady","year":"2015","unstructured":"Mady R, Grover W, Butrus S. Ocular complications of inflammatory bowel disease. ScientificWorldJournal. 2015;2015:438402.","journal-title":"ScientificWorldJournal"},{"key":"3566_CR47","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1053\/gast.2002.35396","volume":"123","author":"TR Orchard","year":"2002","unstructured":"Orchard TR, Chua CN, Ahmad T, Welsh KI, Jewell DP, et al. Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes. Gastroenterology. 2002;123:714\u20138.","journal-title":"Gastroenterology"},{"key":"3566_CR48","doi-asserted-by":"publisher","first-page":"108078","DOI":"10.1016\/j.exer.2020.108078","volume":"197","author":"DPC Vergouwen","year":"2020","unstructured":"Vergouwen DPC, Rothova A, Berge JCT, et al. Current insights in the pathogenesis of scleritis. Exp Eye Res. 2020;197:108078.","journal-title":"Exp Eye Res"},{"key":"3566_CR49","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1136\/bjo.2007.126425","volume":"92","author":"Y Usui","year":"2008","unstructured":"Usui Y, Parikh J, Goto H, et al. Immunopathology of necrotising scleritis. Br J Ophthalmol. 2008;92:417\u20139.","journal-title":"Br J Ophthalmol"},{"key":"3566_CR50","first-page":"153","volume":"16","author":"D Wakefield","year":"2013","unstructured":"Wakefield D, Di Girolamo N, Thurau S, et al. McCluskey P. Scleritis: challenges in immunopathogenesis and treatment. Discov Med. 2013;16:153\u20137.","journal-title":"Discov Med"},{"key":"3566_CR51","unstructured":"Identification of susceptibility SNPs in CTLA-4 and PTPN22 for scleritis in Han Chinese - PubMed. Accessed November 15. 2023. https:\/\/pubmed.ncbi.nlm.nih.gov\/30921471\/"},{"key":"3566_CR52","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/nm1585","volume":"13","author":"A Amadi-Obi","year":"2007","unstructured":"Amadi-Obi A, Yu CR, Liu X, et al. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27\/STAT1. Nat Med. 2007;13:711\u20138.","journal-title":"Nat Med"},{"key":"3566_CR53","unstructured":"Human gut microbiota\/microbiome in health and diseases: a review - PubMed. Accessed November 19. 2023. https:\/\/pubmed.ncbi.nlm.nih.gov\/33136284\/"},{"key":"3566_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10384-015-0416-y","volume":"60","author":"JT Rosenbaum","year":"2016","unstructured":"Rosenbaum JT, Lin P, Asquith M. The microbiome, HLA, and the pathogenesis of uveitis. Jpn J Ophthalmol. 2016;60:1\u20136.","journal-title":"Jpn J Ophthalmol"},{"key":"3566_CR55","doi-asserted-by":"publisher","first-page":"11745","DOI":"10.1038\/s41598-017-12163-3","volume":"7","author":"YK Nakamura","year":"2017","unstructured":"Nakamura YK, Janowitz C, Metea C, et al. Short chain fatty acids ameliorate immune-mediated uveitis partially by altering migration of lymphocytes from the intestine. Sci Rep. 2017;7:11745.","journal-title":"Sci Rep"},{"key":"3566_CR56","unstructured":"Extraintestinal manifestations and complications in IBD - PubMed. Accessed November 16. 2023. https:\/\/pubmed.ncbi.nlm.nih.gov\/23835489\/"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-024-03566-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-024-03566-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-024-03566-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T13:55:41Z","timestamp":1741096541000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-024-03566-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3566"],"URL":"https:\/\/doi.org\/10.1186\/s12876-024-03566-4","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"21 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"135"}}